Product Information
SERTRALINE 150 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $2.5673 per EA under NDC 70710194803. Its NADAC has been published 18 times since Feb 25, 2026.
Strength
150 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710194803
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SERTRALINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA220275On Market Since
1/29/2026
Pharmacological Classes
Price Statistics
The NADAC for SERTRALINE 150 MG CAPSULE has been published 18 times since Feb 25, 2026, and over the history we have for it it has declined 46.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5673 per EA |
|---|---|
| All-time high | $4.8266 (Mar 11, 2026) |
| All-time low | $2.5673 (Jun 17, 2026) |
| 52-week high | $4.8266 |
| 52-week low | $2.5673 |
| Median price | $4.4750 |
| Average price | $4.1862 |
| Largest weekly change | -27.8% (Jun 17, 2026) |
| Weeks tracked | 18 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SERTRALINE 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE 150 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $2.5673 per EA (NDC 70710194803), effective Jun 24, 2026.
How has the price of SERTRALINE 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for SERTRALINE 150 MG CAPSULE has declined 46.8%. It has been tracked across 18 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for SERTRALINE 150 MG CAPSULE?
Since Feb 25, 2026, the NADAC for SERTRALINE 150 MG CAPSULE has ranged from a low of $2.5673 (Jun 17, 2026) to a high of $4.8266 (Mar 11, 2026), with a median of $4.4750 per EA.
Are there cheaper alternatives to SERTRALINE 150 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as SERTRALINE 150 MG CAPSULE, but none are currently priced below it.
Who manufactures SERTRALINE 150 MG CAPSULE?
SERTRALINE 150 MG CAPSULE (NDC 70710194803) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification